U.S. market Closed. Opens in 6 hours 7 minutes

OPRX | OptimizeRx Corporation Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 5.04 - 5.39
52 Week Range 5.04 - 16.65
Beta 1.35
Implied Volatility 75.47%
IV Rank 69.11%
Day's Volume 121,755
Average Volume 123,426
Shares Outstanding 18,321,900
Market Cap 95,457,099
Sector Healthcare
Industry Medical - Healthcare Information Services
IPO Date 2007-11-28
Valuation
Profitability
Growth
Health
P/E Ratio -5.16
Forward P/E Ratio N/A
EPS -1.01
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 135
Country USA
Website OPRX
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
OPRX's peers: FORA, STRM, ACON, HSTM, MDRX, NRC, CPSI, DH, NXGN, DOCS, CERT, HQY, RCM, ACCD, PRVA, AGTI
*Chart delayed
Analyzing fundamentals for OPRX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see OPRX Fundamentals page.

Watching at OPRX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on OPRX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙